Owens & Minor (OMI) to Announce Earnings on Tuesday

Owens & Minor (NYSE:OMI) will likely be releasing its earnings data before the market opens on Tuesday, February 18th. Analysts expect Owens & Minor to post earnings of $0.54 per share and revenue of $2.73 billion for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

Owens & Minor Stock Down 2.1 %

NYSE OMI opened at $8.47 on Tuesday. The stock has a market capitalization of $652.74 million, a P/E ratio of -13.02, a price-to-earnings-growth ratio of 0.25 and a beta of 0.48. Owens & Minor has a 52 week low of $8.39 and a 52 week high of $28.35. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09. The stock has a fifty day moving average of $13.30 and a 200-day moving average of $14.04.

Insiders Place Their Bets

In related news, CFO Jonathan A. Leon sold 5,282 shares of the company’s stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $11.82, for a total value of $62,433.24. Following the completion of the sale, the chief financial officer now owns 130,822 shares in the company, valued at $1,546,316.04. This represents a 3.88 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 3.59% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on OMI shares. Barclays dropped their price objective on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a report on Tuesday, November 5th. UBS Group cut their price objective on shares of Owens & Minor from $28.00 to $25.00 and set a “buy” rating on the stock in a report on Tuesday, November 5th. Robert W. Baird lowered their target price on shares of Owens & Minor from $15.00 to $14.00 and set a “neutral” rating for the company in a report on Tuesday, February 4th. Finally, Citigroup cut their price target on Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research note on Tuesday, November 5th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $18.50.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.